Literature DB >> 9383787

Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet.

N Koohestani1, T T Tran, W Lee, T M Wolever, W R Bruce.   

Abstract

McKeown-Eyssen and Giovannucci recently proposed that the etiology of insulin resistance (IR) and colorectal cancer (CRC) are related. They suggested that diets high in fat and energy and low in complex carbohydrates and a sedentary life-style lead to IR and that the associated hyperinsulinemia, hypertriglyceridemia, and glycemia lead to increased CRC risk through the growth-promoting effect of insulin or the increased availability of energy. We reasoned that if diet affects colon carcinogenesis through its effect on IR, evidence of colon cancer promotion would be preceded by evidence of IR. To test this expectation, we compared the effects of a high-fat (HF, 59% energy) diet and a low-fat (LF, 11% energy) diet on indirect measures of IR and promotion in azoxymethane-initiated F344 rats. Promotion was assessed as growth of aberrant crypt foci (ACF) at 100 days after initiation. The HF diet increased ACF size 1.4 times (95% confidence interval = 1.30-1.58) that of the LF diet. The HF diet also led to impaired oral glucose tolerance tests measured at 4, 32, 60, and 88 days and characterized by an average increased glucose concentration of 0.78 +/- 0.17 mmol/l (p < 0.001). It also resulted in an impaired intravenous glucose tolerance test and elevated levels of serum insulin after a glucose gavage. We concluded that with this model a high-fat diet leads to evidence of IR before it is possible to demonstrate CRC promotion, thus providing support, necessary but not sufficient, for the causal hypothesis linking IR and CRC. Possible mechanisms linking diet, IR, and promotion are considered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9383787     DOI: 10.1080/01635589709514604

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  23 in total

Review 1.  Diabetes mellitus is an independent risk factor for colorectal cancer.

Authors:  Lei Sun; Shiying Yu
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

2.  Insulin resistance, central obesity, and risk of colorectal adenomas.

Authors:  Ana Patricia Ortiz; Cheryl L Thompson; Amitabh Chak; Nathan A Berger; Li Li
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

3.  Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer.

Authors:  Nicole Annette Shonka; James R Anderson; Amit W Panwalkar; Elizabeth C Reed; Preston D Steen; Apar Kishor Ganti
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

4.  Insulin therapy and colorectal adenomas in patients with diabetes mellitus.

Authors:  Patricia Wong; Mark G Weiner; Wei-Ting Hwang; Yu-Xiao Yang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-09       Impact factor: 4.254

Review 5.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

6.  Insulin glargine and NPH insulin increase to a similar degree epithelial cell proliferation and aberrant crypt foci formation in colons of diabetic mice.

Authors:  Jutta M Nagel; Jürgen Staffa; Ingrid Renner-Müller; David Horst; Michael Vogeser; Markus Langkamp; Andreas Hoeflich; Burkhard Göke; Frank T Kolligs; Christos S Mantzoros
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

7.  Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon.

Authors:  D E Corpet; G Peiffer; S Taché
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

8.  Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies.

Authors:  Wu-jie Bu; Lei Song; Dan-yi Zhao; Bing Guo; Jing Liu
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

Review 9.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

10.  Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia.

Authors:  Shuichiro Yamamoto; Toru Nakagawa; Yumi Matsushita; Suzushi Kusano; Takeshi Hayashi; Masataka Irokawa; Takatoshi Aoki; Yukunori Korogi; Tetsuya Mizoue
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.